Jan 2016 $2 M No. 7 Under $2 million 15
Echo Therapeutics, Inc.: Raise no. 7, Jan 2016 × Investors in this round 15 investors had bought by the notice of Feb 8, 2016: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Echo Therapeutics, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $6 M offered; $4 M still to sell
Smallest investment taken $50,000
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions $145,500
Finders' fees none
Paid to its own people $200,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Alan W. Schoenbart · Executive Officer Scott W. Hollander · Executive Officer, Director Elazer R. Edelman · Director Michael M. Goldberg · Director Shepard M. Goldberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Newbridge Securities Corporation (CRD 104065) · Boca Raton, Florida Sold in CA, CT, IL, MA, NJ, NY, SC, TX Remarks in the notice On fees: “+ 8% warrants”On the use of proceeds: “Amount owed to executive officers for unpaid compensation.”Signed by Alan W. Schoenbart, Cfo. Source: SEC Form D, newest notice filed Feb 8, 2016. Read the notice at the SEC .
debt, options SEC Dec 2013 $10 M No. 6 $10 to $50 million 4
Echo Therapeutics, Inc.: Raise no. 6, Dec 2013 × Investors in this round 4 investors had bought by the notice of Dec 19, 2013: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Echo Therapeutics, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $10 M of $10 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher Schnittker · Executive Officer Kimberly Burke · Executive Officer Robert Doman · Executive Officer, Director James Smith · Director Vincent Enright · Director William Grieco · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “This amount includes all of the common stock, preferred stock and warrants”Signed by Kimberly A. Burke, Senior Vice President and General Counsel. Source: SEC Form D, newest notice filed Dec 19, 2013. Read the notice at the SEC .
equity, options SEC Feb 2011 $4 M No. 5 $2 to $10 million 3
Echo Therapeutics, Inc.: Raise no. 5, Feb 2011 × Investors in this round 3 investors had bought by the notice of Feb 15, 2011: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Echo Therapeutics, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken $500,000
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Harry G. Mitchell · Executive Officer Patrick T. Mooney · Executive Officer, Director James F. Smith · Director Shawn K. Singh · Director Vincent D. Enright · Director William F. Grieco · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Harry G. Mitchell, Cfo. Source: SEC Form D, newest notice filed Feb 15, 2011. Read the notice at the SEC .
equity, options SEC Nov 2010 $3 M No. 4 $2 to $10 million 46
Echo Therapeutics, Inc.: Raise no. 4, Nov 2010 × Investors in this round 46 investors had bought by the notice of Feb 15, 2011: 46 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Echo Therapeutics, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $3 M of $3 M offered; $0 M still to sell
Smallest investment taken $10,000
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions $65,625
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Harry G. Mitchell · Executive Officer Patrick T. Mooney · Executive Officer, Director James F. Smith · Director Shawn K. Singh · Director Vincent D. Enright · Director William F. Grieco · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round LifeTech Capital, a division of Aurora Capital, LLC (CRD 37924) · New York, New York Sold in FL, IL, PA, and outside the US Monarch Capital Group, LLC · New York, New York Sold in CA, FL, MA, MN, PA Signed by Harry G. Mitchell, Cfo. Source: SEC Form D, newest notice filed Feb 15, 2011. Read the notice at the SEC .
equity, options SEC Feb 2010 $2 M No. 3 $2 to $10 million 38
Echo Therapeutics, Inc.: Raise no. 3, Feb 2010 × Investors in this round 38 investors had bought by the notice of Oct 21, 2010: 38 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Echo Therapeutics, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $5 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions $140,335
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Harry Mitchell · Executive Officer Patrick Mooney · Executive Officer, Director Shawn Singh · Director Vincent Enright · Director Walter Witoshkin · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round BOENNING & SCATTERGOOD, INC. (CRD 100) · West Conshohocken, Pennsylvania Sold in CA, CT, IL, ME, PA BURNHAM HILL PARTNERS LLC (CRD 148000) · New York, New York Sold in CA, CO, IL, MD, NY Remarks in the notice On fees: “Includes $5,000 expense reimbursement.”Signed by Harry G. Mitchell, Cfo. Source: SEC Form D, newest notice filed Oct 21, 2010. Read the notice at the SEC .
equity, options SEC Nov 2009 $3 M No. 2 $2 to $10 million 8
Echo Therapeutics, Inc.: Raise no. 2, Nov 2009 × Investors in this round 8 investors had bought by the notice of Nov 20, 2009: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Echo Therapeutics, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $3 M of $4 M offered; $1 M still to sell
Smallest investment taken $56,250
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions $154,438
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Harry Mitchell · Executive Officer Patrick Mooney · Executive Officer, Director Robert Langer · Director Shawn Singh · Director Vincent Enright · Director Walter Witoshkin · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round BURNHAM HILL PARTNERS (CRD 148000) · New York, Ny Sold in no state named Remarks in the notice On the amounts: “$805,070 of the amount sold was comprised of non-cash proceeds related to (i) the extinguishment of a Note and (ii) the investment of funds payable by the Company to the investor for a mandatory preferred stock redemption upon closing of this offering.”Signed by Harry G. Mitchell, Cfo. Source: SEC Form D, newest notice filed Nov 20, 2009. Read the notice at the SEC .
equity, options SEC Jul 2009 $2 M No. 1 $2 to $10 million 1
Echo Therapeutics, Inc.: Raise no. 1, Jul 2009 × Investors in this round 1 investor had bought by the notice of Jul 28, 2009: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Echo Therapeutics, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken $2,000,000
What was sold equity
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions $200,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Harry Mitchell · Executive Officer Kimberly Burke · Executive Officer Patrick Mooney · Executive Officer, Director Robert Langer · Director Shawn Singh · Director Vincent Enright · Director Walter Witoshkin · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round BURNHAM HILL PARTNERS (CRD 148000) · New York, Ny Sold in no state named Signed by Harry G. Mitchell, Cfo. Source: SEC Form D, newest notice filed Jul 28, 2009. Read the notice at the SEC .
equity SEC